Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (91-100 of 242) with videos related to

Pageof 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI)Hideyuki Harada, Takashi Seto, Satoshi Igawa, et al.
Surgery Today|October 5, 2011
Prognosis and therapeutic response according to the World Health Organization histological classification in advanced thymomaTetsuzo Tagawa, Takuro Kometani, Koji Yamazaki, et al.
Journal of Thoracic Disease|June 1, 2018
A case of different <i>EGFR</i> mutations in surgically resected synchronous triple lung cancerNaoki Haratake, Mitsuhiro Takenoyama, Makoto Edagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2020
Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503Kaoru Kubota, Hideo Kunitoh, Takashi Seto, et al.
Clinical Lung Cancer|July 20, 2014
Concurrent chemoradiotherapy for patients with postoperative recurrence of surgically resected non-small-cell lung cancerTomoyoshi Takenaka, Mitsuhiro Takenoyama, Ryo Toyozawa, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas<sup>®</sup> EGFR mutation testMiyako Satouchi, Hiroshi Tanaka, Hiroshige Yoshioka, et al.
Journal of Surgical Oncology|March 2, 2010
Non-small cell lung carcinoma of the superior sulcus: The evolution of treatment outcomes with multimodality treatment at a single institutionTetsuzo Tagawa, Atsushi Osoegawa, Koji Yamazaki, et al.
Japanese Journal of Clinical Oncology|December 6, 2019
Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancerMasafumi Yamaguchi, Hideki Hirata, Noriyuki Ebi, et al.
Cancer Treatment and Research Communications|November 26, 2018
First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancerKazuma Kishi, Hiroshi Sakai, Takashi Seto, et al.
Oncology Letters|July 3, 2015
Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancerFumihiko Hirai, Takashi Seto, Eiko Inamasu, et al.
Pageof 25

Showing results (91-100 of 242) with videos related to

Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small-cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005-DI)Hideyuki Harada, Takashi Seto, Satoshi Igawa, et al.
Surgery Today|October 5, 2011
Prognosis and therapeutic response according to the World Health Organization histological classification in advanced thymomaTetsuzo Tagawa, Takuro Kometani, Koji Yamazaki, et al.
Journal of Thoracic Disease|June 1, 2018
A case of different <i>EGFR</i> mutations in surgically resected synchronous triple lung cancerNaoki Haratake, Mitsuhiro Takenoyama, Makoto Edagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2020
Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503Kaoru Kubota, Hideo Kunitoh, Takashi Seto, et al.
Clinical Lung Cancer|July 20, 2014
Concurrent chemoradiotherapy for patients with postoperative recurrence of surgically resected non-small-cell lung cancerTomoyoshi Takenaka, Mitsuhiro Takenoyama, Ryo Toyozawa, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2017
Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas<sup>®</sup> EGFR mutation testMiyako Satouchi, Hiroshi Tanaka, Hiroshige Yoshioka, et al.
Journal of Surgical Oncology|March 2, 2010
Non-small cell lung carcinoma of the superior sulcus: The evolution of treatment outcomes with multimodality treatment at a single institutionTetsuzo Tagawa, Atsushi Osoegawa, Koji Yamazaki, et al.
Japanese Journal of Clinical Oncology|December 6, 2019
Phase II study of vinorelbine plus carboplatin with concurrent radiotherapy in elderly patients with non-small cell lung cancerMasafumi Yamaguchi, Hideki Hirata, Noriyuki Ebi, et al.
Cancer Treatment and Research Communications|November 26, 2018
First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancerKazuma Kishi, Hiroshi Sakai, Takashi Seto, et al.
Oncology Letters|July 3, 2015
Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancerFumihiko Hirai, Takashi Seto, Eiko Inamasu, et al.
Pageof 25